--10 x Genomics, Inc., a leader in single cell and spatial biology, announced today the commercial availability of a new Visium CytAssist Gene and Protein Expression product to expand the breadth ...

The instrument, launched in 2022, streamlines the Visium workflow by allowing expanded sample access, simplifying sample handling and improving data quality for spatial transcriptomic studies. About ...

Now compatible with FFPE, Fresh Frozen and Fixed Frozen tissues, Visium HD delivers high sensitivity and sequencing efficiency with the proven CytAssist-enabled workflow. 10x Genomics revealed ...

A high-level overview of 10x Genomics, Inc. (TXG) stock. View (TXG) real-time stock price, chart, news, analysis, analyst reviews and more.

At the Advances in Genome Biology and Technology (AGBT) General Meeting, 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced a series of new product ...

Visium HD 3' for high resolution, species-agnostic spatial profiling: 10x Genomics unveiled its plans to bring its flagship Visium v1 3' assay, launched in 2019, into high resolution with improvements ...